Attributes | Values |
---|
rdf:type
| |
Description
| - Depending on the excess of ligand used for complex formation, the HIV-protease complexed with a novel phenylnorstatine inhibitor forms crystal either hexagonal (P6(1)) or orthorhombic (P2(1)2(1)) symetry. The orthorhombic form shows an unusual complexity of crystal packing: in addition to one inhibitor molecule that is bound to the enzyme active site, the second inhibitor molecule is bound as an outer ligand at the protein interface
- Depending on the excess of ligand used for complex formation, the HIV-protease complexed with a novel phenylnorstatine inhibitor forms crystal either hexagonal (P6(1)) or orthorhombic (P2(1)2(1)) symetry. The orthorhombic form shows an unusual complexity of crystal packing: in addition to one inhibitor molecule that is bound to the enzyme active site, the second inhibitor molecule is bound as an outer ligand at the protein interface (en)
- V závislosti na nadbytku ligandu využitého pro tvorbu komplexu tvoří HIV-proteáza v komplexu s novým fenylnorstatinovým inhibitorem krystalovou hexagonální (P6(1)) nebo ortorombickou (P2(1)2(1)) symetrii. Ortorombická forma vykazuje neobvyklou komplexnost složení krystalu: kromě jedné molekuly inhibitoru vázané na aktivní místo enzymu je druhá molekula inhibitoru vázána na vnější ligand na proteinovém rozhraní (cs)
|
Title
| - Inhibitor binding at the protein interface in crystals of a HIV-1 protease complex
- Vazba inhibitoru na proteinové rozhraní v krystalu komplexu HIV-1 proteázy (cs)
- Inhibitor binding at the protein interface in crystals of a HIV-1 protease complex (en)
|
skos:prefLabel
| - Inhibitor binding at the protein interface in crystals of a HIV-1 protease complex
- Vazba inhibitoru na proteinové rozhraní v krystalu komplexu HIV-1 proteázy (cs)
- Inhibitor binding at the protein interface in crystals of a HIV-1 protease complex (en)
|
skos:notation
| - RIV/68378050:_____/04:00105299!RIV/2005/AV0/A23005/N
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(LN00B030), Z(AV0Z5052915)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/68378050:_____/04:00105299
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - HIV-1 protease; phenylnorstatine inhibitor; crystal packing (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Acta Crystallographica Section D-Biological Crystallography
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Brynda, Jiří
- Fábry, Milan
- Konvalinka, Jan
- Řezáčová, Pavlína
- Souček, Milan
- Sedláček, Juraj
- Hořejší, Magdalena
- Hradílek, Martin
- Štouračová, Renata
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |